Liberty One Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-549
| Closed | -$147K | – | 186 |
|
|
2024
Q1 | $147K | Sell |
549
-3
| -0.5% | -$801 | 0.02% | 143 |
|
|
2023
Q4 | $128K | Buy |
552
+34
| +7% | +$7.87K | 0.02% | 132 |
|
|
2023
Q3 | $75.6K | Sell |
518
-131
| -20% | -$19.1K | 0.01% | 131 |
|
|
2023
Q2 | $150K | Sell |
649
-980
| -60% | -$226K | 0.02% | 125 |
|
|
2023
Q1 | $395K | Sell |
1,629
-300
| -16% | -$72.7K | 0.05% | 109 |
|
|
2022
Q4 | $560K | Hold |
1,929
| – | – | 0.08% | 104 |
|
|
2022
Q3 | $125K | Buy |
1,929
+183
| +10% | +$11.9K | 0.02% | 130 |
|
|
2022
Q2 | $170K | Sell |
1,746
-171
| -9% | -$16.6K | 0.03% | 127 |
|
|
2022
Q1 | $188K | Sell |
1,917
-441
| -19% | -$43.2K | 0.03% | 126 |
|
|
2021
Q4 | $200K | Buy |
2,358
+639
| +37% | +$54.2K | 0.03% | 126 |
|
|
2021
Q3 | $137K | Sell |
1,719
-27
| -2% | -$2.15K | 0.02% | 135 |
|
|
2021
Q2 | $170K | Buy |
1,746
+394
| +29% | +$38.4K | 0.03% | 138 |
|
|
2021
Q1 | $158K | Buy |
1,352
+685
| +103% | +$80.1K | 0.03% | 133 |
|
|
2020
Q4 | $74K | Buy |
667
+232
| +53% | +$25.7K | 0.01% | 133 |
|
|
2020
Q3 | $52K | Buy |
435
+206
| +90% | +$24.6K | 0.01% | 130 |
|
|
2020
Q2 | $26K | Buy |
+229
| New | +$26K | 0.01% | 131 |
|